nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—Ifosfamide—germ cell cancer	0.117	0.144	CbGbCtD
Zafirlukast—ABCG2—Dactinomycin—germ cell cancer	0.107	0.132	CbGbCtD
Zafirlukast—CYP2C8—Ifosfamide—germ cell cancer	0.0676	0.0829	CbGbCtD
Zafirlukast—ABCG2—Cisplatin—germ cell cancer	0.0617	0.0757	CbGbCtD
Zafirlukast—ABCG2—Etoposide—germ cell cancer	0.0606	0.0743	CbGbCtD
Zafirlukast—CYP2C19—Ifosfamide—germ cell cancer	0.0567	0.0695	CbGbCtD
Zafirlukast—PTGS1—Etoposide—germ cell cancer	0.056	0.0686	CbGbCtD
Zafirlukast—CYP2C9—Ifosfamide—germ cell cancer	0.0471	0.0578	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—germ cell cancer	0.0432	0.053	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—germ cell cancer	0.0401	0.0491	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—germ cell cancer	0.0323	0.0396	CbGbCtD
Zafirlukast—CYP3A4—Ifosfamide—germ cell cancer	0.0274	0.0336	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—germ cell cancer	0.025	0.0307	CbGbCtD
Zafirlukast—CYP2C9—Cisplatin—germ cell cancer	0.0229	0.0281	CbGbCtD
Zafirlukast—CYP2D6—Vinblastine—germ cell cancer	0.0229	0.028	CbGbCtD
Zafirlukast—CYP3A4—Vinblastine—germ cell cancer	0.0145	0.0178	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—germ cell cancer	0.0131	0.0161	CbGbCtD
Zafirlukast—CYP2C9—cardial valve—germ cell cancer	0.00858	0.172	CbGeAlD
Zafirlukast—Hepatitis fulminant—Ifosfamide—germ cell cancer	0.00677	0.0503	CcSEcCtD
Zafirlukast—Raised liver function tests—Dactinomycin—germ cell cancer	0.0035	0.026	CcSEcCtD
Zafirlukast—Numbness—Vinblastine—germ cell cancer	0.00247	0.0184	CcSEcCtD
Zafirlukast—CYP2C19—urine—germ cell cancer	0.00239	0.0478	CbGeAlD
Zafirlukast—Sensory loss—Vinblastine—germ cell cancer	0.00236	0.0176	CcSEcCtD
Zafirlukast—CYSLTR1—trigeminal ganglion—germ cell cancer	0.00233	0.0466	CbGeAlD
Zafirlukast—Rectal haemorrhage—Vinblastine—germ cell cancer	0.00227	0.0169	CcSEcCtD
Zafirlukast—Haematemesis—Ifosfamide—germ cell cancer	0.00213	0.0158	CcSEcCtD
Zafirlukast—Hepatotoxicity—Dactinomycin—germ cell cancer	0.00209	0.0155	CcSEcCtD
Zafirlukast—CYP1A2—urine—germ cell cancer	0.00195	0.039	CbGeAlD
Zafirlukast—Hepatotoxicity—Ifosfamide—germ cell cancer	0.00192	0.0142	CcSEcCtD
Zafirlukast—CYP2C9—urine—germ cell cancer	0.00185	0.037	CbGeAlD
Zafirlukast—CYP2E1—urine—germ cell cancer	0.00175	0.0351	CbGeAlD
Zafirlukast—Hepatotoxicity—Cisplatin—germ cell cancer	0.00165	0.0123	CcSEcCtD
Zafirlukast—Raised liver function tests—Methotrexate—germ cell cancer	0.00152	0.0113	CcSEcCtD
Zafirlukast—Vasculitis—Ifosfamide—germ cell cancer	0.00152	0.0113	CcSEcCtD
Zafirlukast—Liver injury—Cisplatin—germ cell cancer	0.00152	0.0113	CcSEcCtD
Zafirlukast—CYSLTR1—uterus—germ cell cancer	0.00151	0.0303	CbGeAlD
Zafirlukast—Hepatotoxicity—Etoposide—germ cell cancer	0.00151	0.0112	CcSEcCtD
Zafirlukast—Leukocytoclastic vasculitis—Methotrexate—germ cell cancer	0.00143	0.0106	CcSEcCtD
Zafirlukast—CYP3A4—urine—germ cell cancer	0.00141	0.0282	CbGeAlD
Zafirlukast—Numbness—Etoposide—germ cell cancer	0.00141	0.0105	CcSEcCtD
Zafirlukast—CYP2D6—urine—germ cell cancer	0.00139	0.0278	CbGeAlD
Zafirlukast—Injury—Bleomycin—germ cell cancer	0.00137	0.0102	CcSEcCtD
Zafirlukast—Sensory loss—Etoposide—germ cell cancer	0.00135	0.01	CcSEcCtD
Zafirlukast—CYSLTR1—adrenal gland—germ cell cancer	0.00133	0.0266	CbGeAlD
Zafirlukast—Hepatic failure—Dactinomycin—germ cell cancer	0.0013	0.00969	CcSEcCtD
Zafirlukast—CYSLTR1—bone marrow—germ cell cancer	0.00129	0.0257	CbGeAlD
Zafirlukast—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00123	0.00913	CcSEcCtD
Zafirlukast—Swelling—Ifosfamide—germ cell cancer	0.00122	0.00904	CcSEcCtD
Zafirlukast—Neuropathy—Cisplatin—germ cell cancer	0.0012	0.0089	CcSEcCtD
Zafirlukast—Hepatic failure—Ifosfamide—germ cell cancer	0.00119	0.00888	CcSEcCtD
Zafirlukast—CYSLTR1—endocrine gland—germ cell cancer	0.00115	0.0231	CbGeAlD
Zafirlukast—PTGS1—ganglion—germ cell cancer	0.00115	0.023	CbGeAlD
Zafirlukast—CYSLTR1—head—germ cell cancer	0.00114	0.0228	CbGeAlD
Zafirlukast—Neuropathy peripheral—Vinblastine—germ cell cancer	0.00112	0.00835	CcSEcCtD
Zafirlukast—Neuropathy—Etoposide—germ cell cancer	0.0011	0.00815	CcSEcCtD
Zafirlukast—Liver function test abnormal—Dactinomycin—germ cell cancer	0.00108	0.00804	CcSEcCtD
Zafirlukast—Agranulocytosis—Vinblastine—germ cell cancer	0.00107	0.00795	CcSEcCtD
Zafirlukast—Haemoglobin—Vinblastine—germ cell cancer	0.00103	0.00768	CcSEcCtD
Zafirlukast—Haemorrhage—Vinblastine—germ cell cancer	0.00103	0.00765	CcSEcCtD
Zafirlukast—Hypoaesthesia—Vinblastine—germ cell cancer	0.00102	0.00761	CcSEcCtD
Zafirlukast—Haematemesis—Methotrexate—germ cell cancer	0.00101	0.00748	CcSEcCtD
Zafirlukast—PTGS1—endothelium—germ cell cancer	0.000992	0.0199	CbGeAlD
Zafirlukast—Swelling—Etoposide—germ cell cancer	0.000961	0.00714	CcSEcCtD
Zafirlukast—Neutropenia—Dactinomycin—germ cell cancer	0.000947	0.00704	CcSEcCtD
Zafirlukast—PTGS1—blood vessel—germ cell cancer	0.000915	0.0183	CbGeAlD
Zafirlukast—Hepatotoxicity—Methotrexate—germ cell cancer	0.000906	0.00673	CcSEcCtD
Zafirlukast—Haemoglobin—Bleomycin—germ cell cancer	0.000873	0.00649	CcSEcCtD
Zafirlukast—Haemorrhage—Bleomycin—germ cell cancer	0.000869	0.00646	CcSEcCtD
Zafirlukast—Hypoaesthesia—Bleomycin—germ cell cancer	0.000865	0.00642	CcSEcCtD
Zafirlukast—Agranulocytosis—Dactinomycin—germ cell cancer	0.000842	0.00626	CcSEcCtD
Zafirlukast—Ill-defined disorder—Vinblastine—germ cell cancer	0.000831	0.00618	CcSEcCtD
Zafirlukast—CYSLTR1—brain—germ cell cancer	0.000824	0.0165	CbGeAlD
Zafirlukast—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.000811	0.00603	CcSEcCtD
Zafirlukast—Hepatitis—Dactinomycin—germ cell cancer	0.00081	0.00602	CcSEcCtD
Zafirlukast—Malaise—Vinblastine—germ cell cancer	0.000808	0.006	CcSEcCtD
Zafirlukast—CYSLTR1—lymph node—germ cell cancer	0.000796	0.0159	CbGeAlD
Zafirlukast—Agranulocytosis—Ifosfamide—germ cell cancer	0.000772	0.00574	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.000769	0.00572	CcSEcCtD
Zafirlukast—Abdominal discomfort—Cisplatin—germ cell cancer	0.000767	0.0057	CcSEcCtD
Zafirlukast—Discomfort—Vinblastine—germ cell cancer	0.000753	0.0056	CcSEcCtD
Zafirlukast—Haemoglobin—Ifosfamide—germ cell cancer	0.000746	0.00555	CcSEcCtD
Zafirlukast—Hepatitis—Ifosfamide—germ cell cancer	0.000743	0.00552	CcSEcCtD
Zafirlukast—Haemorrhage—Ifosfamide—germ cell cancer	0.000743	0.00552	CcSEcCtD
Zafirlukast—Vasculitis—Methotrexate—germ cell cancer	0.000717	0.00533	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vinblastine—germ cell cancer	0.000716	0.00532	CcSEcCtD
Zafirlukast—Ill-defined disorder—Bleomycin—germ cell cancer	0.000702	0.00522	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Cisplatin—germ cell cancer	0.000699	0.0052	CcSEcCtD
Zafirlukast—Neutropenia—Etoposide—germ cell cancer	0.000685	0.00509	CcSEcCtD
Zafirlukast—Malaise—Bleomycin—germ cell cancer	0.000682	0.00507	CcSEcCtD
Zafirlukast—ABCG2—trigeminal ganglion—germ cell cancer	0.000678	0.0136	CbGeAlD
Zafirlukast—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000655	0.00486	CcSEcCtD
Zafirlukast—Myalgia—Bleomycin—germ cell cancer	0.000644	0.00479	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Etoposide—germ cell cancer	0.00064	0.00476	CcSEcCtD
Zafirlukast—Jaundice—Etoposide—germ cell cancer	0.000637	0.00473	CcSEcCtD
Zafirlukast—Discomfort—Bleomycin—germ cell cancer	0.000636	0.00473	CcSEcCtD
Zafirlukast—Malaise—Dactinomycin—germ cell cancer	0.000636	0.00473	CcSEcCtD
Zafirlukast—Pain—Vinblastine—germ cell cancer	0.000625	0.00464	CcSEcCtD
Zafirlukast—Oedema—Bleomycin—germ cell cancer	0.000617	0.00459	CcSEcCtD
Zafirlukast—Infection—Bleomycin—germ cell cancer	0.000613	0.00456	CcSEcCtD
Zafirlukast—Agranulocytosis—Etoposide—germ cell cancer	0.00061	0.00453	CcSEcCtD
Zafirlukast—Thrombocytopenia—Bleomycin—germ cell cancer	0.000604	0.00449	CcSEcCtD
Zafirlukast—Feeling abnormal—Vinblastine—germ cell cancer	0.000602	0.00448	CcSEcCtD
Zafirlukast—Myalgia—Dactinomycin—germ cell cancer	0.000601	0.00446	CcSEcCtD
Zafirlukast—Ill-defined disorder—Ifosfamide—germ cell cancer	0.0006	0.00446	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000598	0.00444	CcSEcCtD
Zafirlukast—Discomfort—Dactinomycin—germ cell cancer	0.000593	0.00441	CcSEcCtD
Zafirlukast—Angioedema—Ifosfamide—germ cell cancer	0.000591	0.00439	CcSEcCtD
Zafirlukast—Hypoaesthesia—Etoposide—germ cell cancer	0.000584	0.00434	CcSEcCtD
Zafirlukast—Malaise—Ifosfamide—germ cell cancer	0.000583	0.00433	CcSEcCtD
Zafirlukast—Abdominal pain—Vinblastine—germ cell cancer	0.000578	0.00429	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—germ cell cancer	0.000576	0.00428	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—germ cell cancer	0.000572	0.00425	CcSEcCtD
Zafirlukast—Hepatic failure—Methotrexate—germ cell cancer	0.000565	0.0042	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000564	0.00419	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000562	0.00418	CcSEcCtD
Zafirlukast—Myalgia—Ifosfamide—germ cell cancer	0.00055	0.00409	CcSEcCtD
Zafirlukast—Arthralgia—Ifosfamide—germ cell cancer	0.00055	0.00409	CcSEcCtD
Zafirlukast—Discomfort—Ifosfamide—germ cell cancer	0.000544	0.00404	CcSEcCtD
Zafirlukast—Hypersensitivity—Vinblastine—germ cell cancer	0.000539	0.004	CcSEcCtD
Zafirlukast—ABCG2—telencephalon—germ cell cancer	0.000532	0.0107	CbGeAlD
Zafirlukast—Pain—Bleomycin—germ cell cancer	0.000528	0.00392	CcSEcCtD
Zafirlukast—Oedema—Ifosfamide—germ cell cancer	0.000528	0.00392	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000525	0.0039	CcSEcCtD
Zafirlukast—Asthenia—Vinblastine—germ cell cancer	0.000524	0.0039	CcSEcCtD
Zafirlukast—Infection—Ifosfamide—germ cell cancer	0.000524	0.0039	CcSEcCtD
Zafirlukast—Ill-defined disorder—Cisplatin—germ cell cancer	0.000517	0.00384	CcSEcCtD
Zafirlukast—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000517	0.00384	CcSEcCtD
Zafirlukast—Feeling abnormal—Bleomycin—germ cell cancer	0.000509	0.00378	CcSEcCtD
Zafirlukast—ABCG2—decidua—germ cell cancer	0.000504	0.0101	CbGeAlD
Zafirlukast—Malaise—Cisplatin—germ cell cancer	0.000503	0.00373	CcSEcCtD
Zafirlukast—Diarrhoea—Vinblastine—germ cell cancer	0.0005	0.00372	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—germ cell cancer	0.000496	0.00369	CcSEcCtD
Zafirlukast—Back pain—Etoposide—germ cell cancer	0.000494	0.00367	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—germ cell cancer	0.000492	0.00366	CcSEcCtD
Zafirlukast—Urticaria—Bleomycin—germ cell cancer	0.00049	0.00364	CcSEcCtD
Zafirlukast—Body temperature increased—Bleomycin—germ cell cancer	0.000488	0.00363	CcSEcCtD
Zafirlukast—Dizziness—Vinblastine—germ cell cancer	0.000483	0.00359	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000481	0.00357	CcSEcCtD
Zafirlukast—Myalgia—Cisplatin—germ cell cancer	0.000474	0.00353	CcSEcCtD
Zafirlukast—Feeling abnormal—Dactinomycin—germ cell cancer	0.000474	0.00353	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—germ cell cancer	0.000474	0.00352	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000471	0.0035	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—germ cell cancer	0.000469	0.00348	CcSEcCtD
Zafirlukast—Discomfort—Cisplatin—germ cell cancer	0.000469	0.00348	CcSEcCtD
Zafirlukast—Vomiting—Vinblastine—germ cell cancer	0.000465	0.00345	CcSEcCtD
Zafirlukast—CYP2E1—telencephalon—germ cell cancer	0.000461	0.00922	CbGeAlD
Zafirlukast—Malaise—Etoposide—germ cell cancer	0.00046	0.00342	CcSEcCtD
Zafirlukast—Headache—Vinblastine—germ cell cancer	0.000458	0.0034	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000455	0.00338	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—germ cell cancer	0.000455	0.00338	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—germ cell cancer	0.000455	0.00338	CcSEcCtD
Zafirlukast—Fatigue—Ifosfamide—germ cell cancer	0.000455	0.00338	CcSEcCtD
Zafirlukast—Oedema—Cisplatin—germ cell cancer	0.000455	0.00338	CcSEcCtD
Zafirlukast—Hypersensitivity—Bleomycin—germ cell cancer	0.000455	0.00338	CcSEcCtD
Zafirlukast—Infection—Cisplatin—germ cell cancer	0.000452	0.00336	CcSEcCtD
Zafirlukast—Pain—Ifosfamide—germ cell cancer	0.000451	0.00335	CcSEcCtD
Zafirlukast—CYP2C8—pituitary gland—germ cell cancer	0.000446	0.00892	CbGeAlD
Zafirlukast—Thrombocytopenia—Cisplatin—germ cell cancer	0.000445	0.00331	CcSEcCtD
Zafirlukast—PTGS1—telencephalon—germ cell cancer	0.000444	0.00889	CbGeAlD
Zafirlukast—Asthenia—Bleomycin—germ cell cancer	0.000443	0.00329	CcSEcCtD
Zafirlukast—ABCG2—uterus—germ cell cancer	0.000441	0.00883	CbGeAlD
Zafirlukast—Pruritus—Bleomycin—germ cell cancer	0.000437	0.00325	CcSEcCtD
Zafirlukast—Feeling abnormal—Ifosfamide—germ cell cancer	0.000435	0.00323	CcSEcCtD
Zafirlukast—Eosinophilia—Methotrexate—germ cell cancer	0.000435	0.00323	CcSEcCtD
Zafirlukast—Nausea—Vinblastine—germ cell cancer	0.000434	0.00323	CcSEcCtD
Zafirlukast—ABCG2—pituitary gland—germ cell cancer	0.000433	0.00868	CbGeAlD
Zafirlukast—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000431	0.00321	CcSEcCtD
Zafirlukast—Discomfort—Etoposide—germ cell cancer	0.000429	0.00319	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—germ cell cancer	0.000424	0.00315	CcSEcCtD
Zafirlukast—PTGS1—skin of body—germ cell cancer	0.000424	0.00848	CbGeAlD
Zafirlukast—Abdominal discomfort—Methotrexate—germ cell cancer	0.000421	0.00313	CcSEcCtD
Zafirlukast—Urticaria—Ifosfamide—germ cell cancer	0.000419	0.00311	CcSEcCtD
Zafirlukast—ABCG2—medulla oblongata—germ cell cancer	0.000418	0.00837	CbGeAlD
Zafirlukast—Abdominal pain—Ifosfamide—germ cell cancer	0.000417	0.0031	CcSEcCtD
Zafirlukast—Body temperature increased—Ifosfamide—germ cell cancer	0.000417	0.0031	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000414	0.00308	CcSEcCtD
Zafirlukast—Infection—Etoposide—germ cell cancer	0.000414	0.00308	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—germ cell cancer	0.000413	0.00307	CcSEcCtD
Zafirlukast—CYP2D6—brainstem—germ cell cancer	0.000411	0.00823	CbGeAlD
Zafirlukast—Neutropenia—Methotrexate—germ cell cancer	0.00041	0.00305	CcSEcCtD
Zafirlukast—Thrombocytopenia—Etoposide—germ cell cancer	0.000408	0.00303	CcSEcCtD
Zafirlukast—CYP2C19—endocrine gland—germ cell cancer	0.000396	0.00792	CbGeAlD
Zafirlukast—Diarrhoea—Dactinomycin—germ cell cancer	0.000394	0.00293	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000393	0.00292	CcSEcCtD
Zafirlukast—Vomiting—Bleomycin—germ cell cancer	0.000393	0.00292	CcSEcCtD
Zafirlukast—Rash—Bleomycin—germ cell cancer	0.000389	0.00289	CcSEcCtD
Zafirlukast—Pain—Cisplatin—germ cell cancer	0.000389	0.00289	CcSEcCtD
Zafirlukast—Dermatitis—Bleomycin—germ cell cancer	0.000389	0.00289	CcSEcCtD
Zafirlukast—Hypersensitivity—Ifosfamide—germ cell cancer	0.000389	0.00289	CcSEcCtD
Zafirlukast—ABCG2—adrenal gland—germ cell cancer	0.000387	0.00775	CbGeAlD
Zafirlukast—ABCG2—midbrain—germ cell cancer	0.000382	0.00765	CbGeAlD
Zafirlukast—Asthenia—Ifosfamide—germ cell cancer	0.000379	0.00281	CcSEcCtD
Zafirlukast—Feeling abnormal—Cisplatin—germ cell cancer	0.000375	0.00279	CcSEcCtD
Zafirlukast—ABCG2—bone marrow—germ cell cancer	0.000375	0.0075	CbGeAlD
Zafirlukast—Pruritus—Ifosfamide—germ cell cancer	0.000373	0.00277	CcSEcCtD
Zafirlukast—ABCG2—spinal cord—germ cell cancer	0.000373	0.00747	CbGeAlD
Zafirlukast—PTGS1—uterus—germ cell cancer	0.000368	0.00737	CbGeAlD
Zafirlukast—Nausea—Bleomycin—germ cell cancer	0.000367	0.00272	CcSEcCtD
Zafirlukast—Vomiting—Dactinomycin—germ cell cancer	0.000366	0.00272	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—germ cell cancer	0.000365	0.00271	CcSEcCtD
Zafirlukast—CYP2D6—telencephalon—germ cell cancer	0.000365	0.0073	CbGeAlD
Zafirlukast—Rash—Dactinomycin—germ cell cancer	0.000363	0.0027	CcSEcCtD
Zafirlukast—CYP2E1—medulla oblongata—germ cell cancer	0.000362	0.00725	CbGeAlD
Zafirlukast—PTGS1—pituitary gland—germ cell cancer	0.000361	0.00724	CbGeAlD
Zafirlukast—ABCG2—female gonad—germ cell cancer	0.000361	0.00723	CbGeAlD
Zafirlukast—Diarrhoea—Ifosfamide—germ cell cancer	0.000361	0.00268	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00036	0.00267	CcSEcCtD
Zafirlukast—Body temperature increased—Cisplatin—germ cell cancer	0.00036	0.00267	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—germ cell cancer	0.000359	0.00267	CcSEcCtD
Zafirlukast—Pain—Etoposide—germ cell cancer	0.000356	0.00265	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—germ cell cancer	0.000353	0.00262	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—germ cell cancer	0.000351	0.00261	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—germ cell cancer	0.000351	0.00261	CcSEcCtD
Zafirlukast—Dizziness—Ifosfamide—germ cell cancer	0.000349	0.00259	CcSEcCtD
Zafirlukast—CYP2C8—endocrine gland—germ cell cancer	0.000345	0.00691	CbGeAlD
Zafirlukast—Feeling abnormal—Etoposide—germ cell cancer	0.000343	0.00255	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—germ cell cancer	0.000342	0.00254	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Etoposide—germ cell cancer	0.000341	0.00253	CcSEcCtD
Zafirlukast—Vomiting—Ifosfamide—germ cell cancer	0.000335	0.00249	CcSEcCtD
Zafirlukast—CYP2E1—adrenal gland—germ cell cancer	0.000335	0.00671	CbGeAlD
Zafirlukast—Hypersensitivity—Cisplatin—germ cell cancer	0.000335	0.00249	CcSEcCtD
Zafirlukast—Rash—Ifosfamide—germ cell cancer	0.000333	0.00247	CcSEcCtD
Zafirlukast—Dermatitis—Ifosfamide—germ cell cancer	0.000332	0.00247	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—germ cell cancer	0.000331	0.00246	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—germ cell cancer	0.000329	0.00245	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—germ cell cancer	0.000329	0.00245	CcSEcCtD
Zafirlukast—CYP2C8—testis—germ cell cancer	0.000329	0.00659	CbGeAlD
Zafirlukast—Asthenia—Cisplatin—germ cell cancer	0.000326	0.00243	CcSEcCtD
Zafirlukast—CYP1A2—endocrine gland—germ cell cancer	0.000323	0.00647	CbGeAlD
Zafirlukast—PTGS1—adrenal gland—germ cell cancer	0.000323	0.00646	CbGeAlD
Zafirlukast—CYP2E1—spinal cord—germ cell cancer	0.000323	0.00646	CbGeAlD
Zafirlukast—ABCG2—testis—germ cell cancer	0.00032	0.00641	CbGeAlD
Zafirlukast—Nausea—Ifosfamide—germ cell cancer	0.000313	0.00233	CcSEcCtD
Zafirlukast—Diarrhoea—Cisplatin—germ cell cancer	0.000311	0.00231	CcSEcCtD
Zafirlukast—PTGS1—spinal cord—germ cell cancer	0.000311	0.00623	CbGeAlD
Zafirlukast—Hypersensitivity—Etoposide—germ cell cancer	0.000307	0.00228	CcSEcCtD
Zafirlukast—CYP2C9—endocrine gland—germ cell cancer	0.000307	0.00614	CbGeAlD
Zafirlukast—PTGS1—female gonad—germ cell cancer	0.000301	0.00603	CbGeAlD
Zafirlukast—Asthenia—Etoposide—germ cell cancer	0.000299	0.00222	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—germ cell cancer	0.000296	0.0022	CcSEcCtD
Zafirlukast—ABCG2—cerebellum—germ cell cancer	0.000296	0.00592	CbGeAlD
Zafirlukast—Pruritus—Etoposide—germ cell cancer	0.000295	0.00219	CcSEcCtD
Zafirlukast—CYP2E1—endocrine gland—germ cell cancer	0.000291	0.00582	CbGeAlD
Zafirlukast—Vomiting—Cisplatin—germ cell cancer	0.000289	0.00215	CcSEcCtD
Zafirlukast—CYP2E1—head—germ cell cancer	0.000287	0.00574	CbGeAlD
Zafirlukast—Rash—Cisplatin—germ cell cancer	0.000287	0.00213	CcSEcCtD
Zafirlukast—Dermatitis—Cisplatin—germ cell cancer	0.000287	0.00213	CcSEcCtD
Zafirlukast—Diarrhoea—Etoposide—germ cell cancer	0.000285	0.00212	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—germ cell cancer	0.000284	0.00211	CcSEcCtD
Zafirlukast—PTGS1—endocrine gland—germ cell cancer	0.00028	0.00561	CbGeAlD
Zafirlukast—CYP2E1—testis—germ cell cancer	0.000277	0.00555	CbGeAlD
Zafirlukast—PTGS1—head—germ cell cancer	0.000276	0.00553	CbGeAlD
Zafirlukast—Malaise—Methotrexate—germ cell cancer	0.000276	0.00205	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—germ cell cancer	0.000276	0.00205	CcSEcCtD
Zafirlukast—Nausea—Cisplatin—germ cell cancer	0.00027	0.00201	CcSEcCtD
Zafirlukast—PTGS1—testis—germ cell cancer	0.000267	0.00535	CbGeAlD
Zafirlukast—Vomiting—Etoposide—germ cell cancer	0.000265	0.00197	CcSEcCtD
Zafirlukast—Rash—Etoposide—germ cell cancer	0.000263	0.00195	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—germ cell cancer	0.000262	0.00195	CcSEcCtD
Zafirlukast—Headache—Etoposide—germ cell cancer	0.000261	0.00194	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—germ cell cancer	0.00026	0.00193	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—germ cell cancer	0.00026	0.00193	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—germ cell cancer	0.000257	0.00191	CcSEcCtD
Zafirlukast—CYP2E1—cerebellum—germ cell cancer	0.000256	0.00512	CbGeAlD
Zafirlukast—Infection—Methotrexate—germ cell cancer	0.000248	0.00184	CcSEcCtD
Zafirlukast—Nausea—Etoposide—germ cell cancer	0.000248	0.00184	CcSEcCtD
Zafirlukast—CYP2D6—female gonad—germ cell cancer	0.000247	0.00495	CbGeAlD
Zafirlukast—CYP2C8—brain—germ cell cancer	0.000247	0.00495	CbGeAlD
Zafirlukast—Thrombocytopenia—Methotrexate—germ cell cancer	0.000244	0.00182	CcSEcCtD
Zafirlukast—ABCG2—brain—germ cell cancer	0.00024	0.00481	CbGeAlD
Zafirlukast—CYP3A4—endocrine gland—germ cell cancer	0.000234	0.00468	CbGeAlD
Zafirlukast—ABCG2—lymph node—germ cell cancer	0.000232	0.00465	CbGeAlD
Zafirlukast—CYP2D6—endocrine gland—germ cell cancer	0.00023	0.00461	CbGeAlD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000227	0.00169	CcSEcCtD
Zafirlukast—CYP2D6—head—germ cell cancer	0.000227	0.00455	CbGeAlD
Zafirlukast—Insomnia—Methotrexate—germ cell cancer	0.000226	0.00168	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—germ cell cancer	0.00022	0.00163	CcSEcCtD
Zafirlukast—CYP2D6—testis—germ cell cancer	0.000219	0.00439	CbGeAlD
Zafirlukast—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000215	0.0016	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—germ cell cancer	0.000215	0.0016	CcSEcCtD
Zafirlukast—Pain—Methotrexate—germ cell cancer	0.000213	0.00159	CcSEcCtD
Zafirlukast—CYP2E1—brain—germ cell cancer	0.000208	0.00416	CbGeAlD
Zafirlukast—Feeling abnormal—Methotrexate—germ cell cancer	0.000206	0.00153	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000204	0.00152	CcSEcCtD
Zafirlukast—CYP2D6—cerebellum—germ cell cancer	0.000203	0.00406	CbGeAlD
Zafirlukast—PTGS1—brain—germ cell cancer	0.0002	0.00401	CbGeAlD
Zafirlukast—Urticaria—Methotrexate—germ cell cancer	0.000198	0.00147	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—germ cell cancer	0.000197	0.00147	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—germ cell cancer	0.000197	0.00147	CcSEcCtD
Zafirlukast—PTGS1—lymph node—germ cell cancer	0.000194	0.00387	CbGeAlD
Zafirlukast—Hypersensitivity—Methotrexate—germ cell cancer	0.000184	0.00137	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—germ cell cancer	0.000179	0.00133	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—germ cell cancer	0.000177	0.00131	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—germ cell cancer	0.000171	0.00127	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—germ cell cancer	0.000165	0.00123	CcSEcCtD
Zafirlukast—CYP2D6—brain—germ cell cancer	0.000165	0.0033	CbGeAlD
Zafirlukast—Vomiting—Methotrexate—germ cell cancer	0.000159	0.00118	CcSEcCtD
Zafirlukast—Rash—Methotrexate—germ cell cancer	0.000157	0.00117	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—germ cell cancer	0.000157	0.00117	CcSEcCtD
Zafirlukast—Headache—Methotrexate—germ cell cancer	0.000156	0.00116	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—germ cell cancer	0.000148	0.0011	CcSEcCtD
